Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) Return on Assets: 2022-2025

Historic Return on Assets for Prime Medicine (PRME) over the last 3 years, with Sep 2025 value amounting to -0.60%.

  • Prime Medicine's Return on Assets rose 14.00% to -0.60% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.60%, marking a year-over-year increase of 14.00%. This contributed to the annual value of -0.80% for FY2024, which is 8.00% down from last year.
  • Prime Medicine's Return on Assets amounted to -0.60% in Q3 2025, which was up 8.42% from -0.66% recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's Return on Assets ranged from a high of -0.41% in Q1 2023 and a low of -0.92% during Q4 2023.
  • Over the past 3 years, Prime Medicine's median Return on Assets value was -0.66% (recorded in 2025), while the average stood at -0.67%.
  • In the last 5 years, Prime Medicine's Return on Assets plummeted by 49bps in 2023 and then increased by 29bps in 2024.
  • Quarterly analysis of 4 years shows Prime Medicine's Return on Assets stood at -0.42% in 2022, then plummeted by 49bps to -0.92% in 2023, then rose by 29bps to -0.62% in 2024, then rose by 14bps to -0.60% in 2025.
  • Its last three reported values are -0.60% in Q3 2025, -0.66% for Q2 2025, and -0.65% during Q1 2025.